Tumor-Cell Targeted Epidermal Growth Factor Liposomes Loaded with Boronated Acridine: Uptake and Processing

[1]  K. Edwards,et al.  Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. , 2002, Bioconjugate chemistry.

[2]  U. Nielsen,et al.  Tumor targeting using anti-her2 immunoliposomes. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Zignani,et al.  Current status of pH-sensitive liposomes in drug delivery. , 2000, Progress in lipid research.

[4]  L. Pilarski,et al.  Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo. , 2000, Biochimica et biophysica acta.

[5]  D. Tzemach,et al.  Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  H. Lundqvist,et al.  Radiation doses to the cell nucleus in single cells and cells in micrometastases in targeted therapy with (131)I labeled ligands or antibodies. , 2000, International journal of radiation oncology, biology, physics.

[7]  C. Benz,et al.  Liposome targeting to tumors using vitamin and growth factor receptors. , 2000, Vitamins and hormones.

[8]  Koning,et al.  Immunoliposomes for the targeted delivery of antitumor drugs. , 1999, Advanced drug delivery reviews.

[9]  D. Tzemach,et al.  Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. , 1999, Bioconjugate chemistry.

[10]  K. Edwards,et al.  Optimization of Drug Loading Procedures and Characterization of Liposomal Formulations of Two Novel Agents Intended for Boron Neutron Capture Therapy (BNCT) , 1999 .

[11]  L. Pilarski,et al.  Cellular Trafficking and Cytotoxicity of Anti-Cd19-Targeted Liposomal Doxorubicin in B Lymphoma Cells , 1999 .

[12]  W. Tjarks,et al.  Synthesis of novel boronated acridines- and spermidines as possible agents for BNCT , 1998 .

[13]  S. Simões,et al.  Sterically Stabilized pH-sensitive Liposomes , 1997, The Journal of Biological Chemistry.

[14]  H. Arima,et al.  Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. , 1996, Biochemical and biophysical research communications.

[15]  R. Barth,et al.  Boron neutron capture therapy of brain tumors: past history, current status, and future potential. , 1996, Cancer investigation.

[16]  M. Stuart,et al.  Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. , 1995, Biochimica et biophysica acta.

[17]  T. Allen,et al.  A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. , 1995, Biochimica et biophysica acta.

[18]  H. Lundqvist,et al.  Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor. , 1994, International journal of radiation oncology, biology, physics.

[19]  J. Carlsson,et al.  Internalization and excretion of epidermal growth factor‐dextran‐associated radioactivity in cultured human squamous‐carcinoma cells , 1994, International journal of cancer.

[20]  J. Carlsson,et al.  New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells. , 1994, Anti-cancer drugs.

[21]  G. Storm,et al.  Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. , 1993, The Journal of infectious diseases.

[22]  C. Waters,et al.  Endocytosis of growth factor receptors , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[23]  A. Gabizon.  Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. , 1992, Cancer research.

[24]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[26]  Y. Aramaki,et al.  Preparation of EGF labeled liposomes and their uptake by hepatocytes. , 1989, Biochemical and biophysical research communications.

[27]  C. Heldin,et al.  Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells , 1982, Journal of neuroscience research.

[28]  I. Pastan,et al.  Dansylcadaverine inhibits internalization of 125I-epidermal growth factor in BALB 3T3 cells. , 1980, The Journal of biological chemistry.

[29]  S. Singer,et al.  Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G Gregoriadis,et al.  Drug-carrier potential of liposomes in cancer chemotherapy. , 1974, Lancet.